FilingPulse

ALXO insider transaction filings

ALX ONCOLOGY HOLDINGS INC — 41 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-18. Screen ALXO transaction legs live →

FiledFormInsiderReported transactionsSource
2026-08-184Wong Shelly — SVP, FINANCE AND CAOSale (S): 573 @ $1.93EDGAR
2026-08-184Lettmann Jason — CHIEF EXECUTIVE OFFICER, DirectorSale (S): 2,230 @ $1.93EDGAR
2026-07-064Wong Shelly — SVP, FINANCE AND CAOSale (S): 1,404 @ $2.04EDGAR
2026-04-174Knight Jeff E. — Chief Dev & Operating OfficerGrant/award (A): 800,000 (derivative) @ $0EDGAR
2026-04-174Klencke Barbara — Chief Medical OfficerGrant/award (A): 100,000 (derivative) @ $0EDGAR
2026-03-234Pinto Shelly — SVP, FINANCE AND CAOSale (S): 903 @ $2.17EDGAR
2026-03-234Lettmann Jason — CHIEF EXECUTIVE OFFICER, DirectorSale (S): 12,311 @ $2.17EDGAR
2026-03-054Klencke Barbara — Chief Medical OfficerGrant/award (A): 700,000 (derivative) @ $0EDGAR
2026-02-204Pinto Shelly — SVP, FINANCE AND CAOSale (S): 565 @ $2.27EDGAR
2026-02-194Lettmann Jason — CHIEF EXECUTIVE OFFICER, DirectorTax withholding (F): 2,201 @ $2.27EDGAR
2026-02-044GOODMAN COREY S — Director, 10% ownerPurchase (P): 3,184,713 @ $1.57EDGAR
2026-01-284Shantharam Harish — Chief Financial OfficerGrant/award (A): 303,000 (derivative) @ $0EDGAR
2026-01-284Pinto Shelly — SVP, FINANCE AND CAOGrant/award (A): 192,000 (derivative) @ $0EDGAR
2026-01-284Lettmann Jason — CHIEF EXECUTIVE OFFICER, DirectorGrant/award (A): 912,000 (derivative) @ $0EDGAR
2026-01-214Sandler Alan B. — DirectorGrant/award (A): 10,100 (derivative) @ $0EDGAR
2026-01-214Curran Daniel J. — DirectorGrant/award (A): 16,833 (derivative) @ $0EDGAR
2026-01-214Hemrajani Rekha — DirectorGrant/award (A): 40,400 (derivative) @ $0EDGAR
2026-01-214Takimoto Chris H — DirectorGrant/award (A): 40,400 (derivative) @ $0EDGAR
2026-01-214Garland J. Scott — DirectorGrant/award (A): 40,400 (derivative) @ $0EDGAR
2026-01-214GOODMAN COREY S — Director, 10% ownerGrant/award (A): 40,400 (derivative) @ $0EDGAR
2026-01-074Pinto Shelly — SVP, FINANCE AND CAOSale (S): 3,925 @ $1.11EDGAR
2025-10-164Pinto Shelly — SVP, FINANCE AND CAOGrant/award (A): 140,000 (derivative) @ $0EDGAR
2025-10-164Shantharam Harish — Chief Financial OfficerGrant/award (A): 198,750 (derivative) @ $0EDGAR
2025-10-164Lettmann Jason — CHIEF EXECUTIVE OFFICER, DirectorGrant/award (A): 597,500 (derivative) @ $0EDGAR
2025-09-194Klencke Barbara — DirectorGrant/award (A): 300,000 (derivative) @ $0EDGAR
2025-09-184Lettmann Jason — CHIEF EXECUTIVE OFFICER, DirectorPurchase (P): 21,070 @ $1.07 · Purchase (P): 71,163 @ $1.08EDGAR
2025-08-204Shantharam Harish — Chief Financial OfficerPurchase (P): 75,000 @ $0.78EDGAR
2025-08-194Pinto Shelly — SVP, FINANCE AND CAOSale (S): 611 @ $0.64EDGAR
2025-08-194Lettmann Jason — CHIEF EXECUTIVE OFFICER, DirectorSale (S): 2,382 @ $0.64EDGAR
2025-08-134Curran Daniel J. — DirectorGrant/award (A): 40,400 (derivative) @ $0EDGAR
2025-07-084Pinto Shelly — SVP, FINANCE AND CAOSale (S): 2,011 @ $0.45EDGAR
2025-07-014Pinto Shelly — SVP, FINANCE AND CAOSale (S): 1,532 @ $0.43EDGAR
2025-04-154Pinto Shelly — SVP, FINANCE AND CAOGrant/award (A): 90,000 (derivative) @ $0EDGAR
2025-04-154Sandler Alan B. — Chief Medical OfficerGrant/award (A): 125,000 (derivative) @ $0EDGAR
2025-04-154Shantharam Harish — Chief Financial OfficerGrant/award (A): 125,000 (derivative) @ $0EDGAR
2025-04-154Lettmann Jason — CHIEF EXECUTIVE OFFICER, DirectorGrant/award (A): 125,000 (derivative) @ $0EDGAR
2025-03-184Pinto Shelly — SVP, FINANCE AND CAOGrant/award (A): 3,000 @ $0EDGAR
2025-03-184Lettmann Jason — CHIEF EXECUTIVE OFFICER, DirectorGrant/award (A): 42,000 @ $0EDGAR
2025-02-214Pinto Shelly — SVP, FINANCE AND CAOSale (S): 550 @ $1.15EDGAR
2025-02-214Pons Jaume — PRESIDENT & CSOSale (S): 1,326 @ $1.15EDGAR
2025-02-214Lettmann Jason — CHIEF EXECUTIVE OFFICER, DirectorSale (S): 2,159 @ $1.15EDGAR

Recent 8-K events — ALX ONCOLOGY HOLDINGS INC

FiledFormItems reportedSource
2026-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-308-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-268-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-118-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-088-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-04-138-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-02-278-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-01-308-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-01-308-K8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-01-218-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits		EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ALXO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →